PANCREATIC KININOGENASE ENTERIC-COATED TABLETS

Efficacy:
Diabetes complicated with vascular diseases, such as diabetic nephropathy, fundus lesions, neuropathy. Ischemic cerebrovascular disease. Mild and moderate primary and secondary hypertension.

Usage and Dosage:
Oral administration on an empty stomach, 120~240U at a time, 3 times/day; before intramuscular injection, add 1.5ml of sterile injection water or 0.9% sodium chloride injection to dissolve, intramuscular injection, 10~40U/day, once/day or once every other day.

Adverse reactions:
Gastrointestinal discomfort, fatigue, occasional rash, itching and other allergic phenomena may occur.

Drug contraindications:
Allergic to this product is prohibited